Steris (STE) Long-Term Debt Issuances (2021)

Steris' (STE) quarterly Long-Term Debt Issuances came in at -$700.0 million in Q3 2021, down 151.85% quarter-over-quarter from $1.4 billion in Q2 2021.

Steris (STE) Long-Term Debt Issuances (2021) Analysis & Trends

Steris' Long-Term Debt Issuances history runs 1 years deep, the most recent figure standing at -$700.0 million for Q3 2021.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to -$700.0 million in Q3 2021; TTM through Jun 2022 was -$700.0 million, a 136.84% decrease from a year earlier, with the FY2022 full-year figure at $650.0 million, up 18.18% from the prior year.
  • Long-Term Debt Issuances declined to -$700.0 million in Q3 2021 per STE's latest filing, from $1.4 billion in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $1.4 billion in Q2 2021 and bottomed at -$700.0 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Abbott Laboratories 182.81 Bn 175.52 Bn 6.27 Bn 19.86 Bn
2 Stryker 128.98 Bn 126.10 Bn 3.81 Bn -
3 Medtronic 108.67 Bn 99.45 Bn 6.41 Bn -
4 Boston Scientific 68.36 Bn 66.91 Bn 3.61 Bn -
5 Edwards Lifesciences 47.70 Bn 44.03 Bn 1.29 Bn -
6 Dexcom 28.67 Bn 27.55 Bn 750.30 Mn -
7 GE HealthCare Technologies 28.55 Bn 26.27 Bn 1.98 Bn 1.15 Bn
8 Smith & Nephew 26.97 Bn 26.40 Bn - -
9 Koninklijke Philips 25.45 Bn 22.33 Bn 2.07 Bn 11.71 Mn
10 Steris 21.46 Bn 21.02 Bn 697.10 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2021 -700.00 Mn
Sep 30, 2021 -700.00 Mn
Jun 30, 2021 1.35 Bn
Jun 30, 2021 1.35 Bn
Mar 31, 2021 550.00 Mn
Mar 31, 2021 550.00 Mn